Charles J Dimitroff

6PUBLICATIONS

28CO-AUTHORS

Molecular targetsPredictive and prognostic markersTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 28, 2026

ST6GAL1 Glycoengineering Rewires Cytokine Signaling and Preserves Metabolic Fitness in CAR-T Cells Under Galectin-3-Mediated Immunosuppression.

|Nov 13, 2025

TILDA-X: Transcriptome-Informed Lung Cancer Disparities via Explainable AI.

Masrur Sobhan, Md Mezbahul Islam, Mary Jo Trepka

|May 28, 2025

Melanoma Glycome Regulates the Pro-Oncogenic Properties of Extracellular Galectin-3.

Norhan B B Mohammed, Rajib K Shil, Charles J Dimitroff

|Dec 23, 2022

Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.

Lee Seng Lau, Norhan B B Mohammed, Charles J Dimitroff

|Aug 18, 2022

Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis.

Tobias Schatton, Yuta Itoh, Christina Martins

|Mar 04, 2021

Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.

M Perez, A Chakraborty, L S Lau

Pageof 1

Frequent Collaborators

Lee Seng Lau

Tobias Schatton

Yuta Itoh

Christina Martins

Erik Rasbach

Praveen Singh

Mariana Silva

Kyla Mucciarone

Markus V Heppt

Jenna Geddes-Sweeney

Frequent Collaborators

Lee Seng Lau

Tobias Schatton

Yuta Itoh

Christina Martins